H. Salem

发表

Binding of activated protein C to a specific receptor on human mononuclear phagocytes inhibits intracellular calcium signaling and monocyte-dependent proliferative responses.

S. Grey, M. Sayegh, W. Hancock, 1995, Transplantation.

Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis

H. Salem, 2005 .

Thrombomodulin, an endothelial anticoagulant protein, is absent from the human brain

C. Bell, P. Majerus, H. Ishii, 1986 .

Inhibition of activated protein C by platelets.

S. Jane, C. Mitchell, L. Hau, 1989, The Journal of clinical investigation.

Thrombomodulin, an endothelial anticoagulant protein, is absent from the human brain.

C. Bell, P. Majerus, H. Ishii, 1986, Blood.

Antiphospholipid antibodies and thrombosis: assessment of the potential risk for thrombosis

H. Salem, HH Salem, 1996 .

The anticoagulants protein C and protein S display potent antiinflammatory and immunosuppressive effects relevant to transplant biology and therapy.

W. Hancock, A. Tsuchida, N. Thomson, 1992, Transplantation proceedings.

Prothrombin complex concentrates used alone in urgent reversal of warfarin anticoagulation

M. Collecutt, H. Tran, H. Salem, 2011, Internal medicine journal.

Tumor necrosis factor production during human renal allograft rejection is associated with depression of plasma protein C and free protein S levels and decreased intragraft thrombomodulin expression

W. Hancock, A. Tsuchida, N. Thomson, 1992, The Journal of experimental medicine.

Construction and characterization of a chimeric protein consisting of tissue-type plasminogen activator and the epidermal growth factor-like regions of thrombomodulin☆

P. Bird, H. Salem, M. A. Myers, 1994 .

Nucleolar and cytoplasmic localization of annexin V

P. Bird, Jiuru Sun, Philip I Bird, 1992, FEBS letters.

The regulation of human factor V by a neutrophil protease.

H. Salem, A. Oates, 1987, Blood.

Biosynthesis of coagulation Factor V by a human hepatocellular carcinoma cell line.

P. Majerus, I. Maruyama, D. B. Wilson, 1984, The Journal of clinical investigation.

Isolation and characterization of thrombomodulin from human placenta.

P. Majerus, I. Maruyama, H. Ishii, 1984, The Journal of biological chemistry.

Human thrombomodulin is not an efficient inhibitor of the procoagulant activity of thrombin.

P. Majerus, I. Maruyama, H. Ishii, 1985, The Journal of clinical investigation.

Influence of Thermal Cyclers on Day-to-Day Reproducibility of Random Amplified Polymorphic DNA Fingerprints

H. Salem, A. Ali, H. T. Huang, 2006 .

A fatal thrombotic disorder associated with an acquired inhibitor of protein C.

C. Mitchell, L. Hau, H. Salem, 1987, The New England journal of medicine.

Direct-acting Oral Anticoagulants: An Overview

H. Salem, 2017, Saudi journal of medicine & medical sciences.

Beta-thromboglobulin and platelet aggregates in glomerulonephritis.

J. Whitworth, A. D'apice, H. Salem, 1980, Clinical nephrology.

Studies of natural anticoagulant proteins and anticardiolipin antibodies in patients with the lupus anticoagulant

S. Lo, H. Salem, B. Firkin, 1990, British journal of haematology.

Pruritus and severe iron deficiency in polycythaemia vera.

J. Wiley, H. Salem, M. van der Weyden, 1982, British medical journal.

Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis

E. Wood, P. Coughlin, A. Gallus, 2004, The Medical journal of Australia.

Coagulation factor Va binds to human umbilical vein endothelial cells and accelerates protein C activation.

P. Majerus, I. Maruyama, H. Salem, 1984, The Journal of clinical investigation.

Human coagulation factor Va is a cofactor for the activation of protein C.

J. Miletich, P. Majerus, G. Broze, 1983, Proceedings of the National Academy of Sciences of the United States of America.

Platelet aggregating activity in the plasma of patients with established thrombosis.

S. Jackson, H. Salem, 1989, Australian and New Zealand journal of medicine.

Leg pain and platelet aggregates in thrombocythemic myeloproliferative disease.

J. Koutts, H. Salem, B. Firkin, 1980, JAMA.

Circulating platelet aggregates in ischaemic heart disease and their correlation to platelet life span.

J. Koutts, H. Salem, B. Firkin, 1980, Thrombosis research.

Fast migrating protein, immunochemically related to human factor VIII, studied by crossed immunoelectrophoresis in agarose

H. H. Salem, H. Salem, B. Firkin, 1983, British journal of haematology.

Altered Thrombomodulin Staining In Blistering Dermatoses

C. Mitchell, J. Hayman, G. Mason, 1996, Pathology.

Coagulopathy of peritoneovenous shunts: studies on the pathogenic role of ascitic fluid collagen and value of antiplatelet therapy.

J. Perkin, H. Salem, F. Dudley, 1983, Gut.

Complex Interaction between Factor Va‐Light Chain and Thrombomodulin in the Regulation of Protein C Activation a

C. Esmon, P. Majerus, N. Esmon, 1986, Annals of the New York Academy of Sciences.

The agglutination of human platelets by botrocetin: evidence that botrocetin and ristocetin act at different sites on the factor VIII molecule and platelet membrane

J. Perkin, H. Salem, M. Howard, 1984, British journal of haematology.

IRON OVERLOAD IN CONGENITAL ERYTHROCYTE PYRUVATE KINASE DEFICIENCY

H. Salem, B. Firkin, M. van der Weyden, 1980, The Medical journal of Australia.

TNF as a mediator of cardiac transplant rejection, including effects on the intragraft protein C/protein S/thrombomodulin pathway.

R. Atkins, J. Kupiec-Weglinski, W. Hancock, 1991, Transplantation proceedings.

The binding and regulation of protein S by neutrophils

H. Salem, A. Oates, 1991, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Cleavage of protein S by a platelet membrane protease.

C. Mitchell, H. Salem, 1987, The Journal of clinical investigation.

Effects of annexin V on the activity of the anticoagulant proteins C and S.

P. Bird, J. Sun, H. Salem, 1993, Thrombosis research.

The Anticoagulant Properties of a Modified Form of Protein S

C. Mitchell, H. Salem, S. Kelemen, 1988, Thrombosis and Haemostasis.

Interaction of annexin V and platelets: effects on platelet function and protein S binding.

P. Bird, J. Sun, H. Salem, 1993, Thrombosis research.

Variant von Willebrand's disease type B--revisited.

K. B. Thomas, J. Perkin, L. Hau, 1982, Blood.

Selective effects of protein C on activation of human monocytes by lipopolysaccharide, interferon-gamma, or PMA: modulation of effects on CD11b and CD14 but not CD25 or CD54 induction.

S. Grey, W. Hancock, H. Salem, 1993, Transplantation proceedings.

Detection of Full Length Hb S Gene (1.2 Kb) in One- and Two-cell Embryo Originated from Hamster Oocyte and Human Spermatozoa by Using Nested-PCR

H. Salem, H. T. Huang, D. Xie, 2006 .

Aggregation of human platelets by amniotic fluid

W. Walters, J. Perkin, H. Salem, 1982, British journal of obstetrics and gynaecology.

Immunohistochemical localization of thrombomodulin in normal human skin and skin tumours

D. Jackson, C. A. Mitchell, P. Bird, 1995, The Journal of pathology.

value of antiplatelet therapy . role of ascitic fluid collagen and shunts : studies on the pathogenic Coagulopathy of peritoneovenous

J. Perkin, H. Salem, F. Dudley, 2006 .

Coagulopathy during ascites reinfusion: prevention by antiplatelet therapy.

L. Wood, H. Salem, F. Dudley, 1992, Gastroenterology.

Investigation of a coagulation accelerating factor (CAF) in glomerulonephritis

J. Koutts, H. Salem, B. Firkin, 1985, British journal of haematology.

Association of annexin V with mitochondria

P. Bird, Jiuru Sun, C. Bird, 1993, FEBS letters.

Chromosomal mapping of the human proteinase inhibitor 6 (PI6) gene to 6p25 by fluorescence in situ hybridization.

G. Sutherland, P. Bird, P. Coughlin, 1995, Genomics.

Inhibition by human thrombomodulin of factor Xa-mediated cleavage of prothrombin.

H. Salem, E. Thompson, 1986, The Journal of clinical investigation.

The anticoagulant properties of thrombomodulin

C. Bell, P. Majerus, C. Mitchell, 1986 .

Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-gamma, or phorbol ester.

S. Grey, W. Hancock, A. Tsuchida, 1994, Journal of immunology.

Inhibition of the anticoagulant activity of protein S by prothrombin.

S. Jane, C. Mitchell, H. Salem, 1988, The Journal of clinical investigation.

Purification and characterization of two forms of soluble thrombomodulin from human urine.

T. Tetaz, C. Mitchell, H. Salem, 1994, European journal of biochemistry.

The light chain of factor Va contains the activity of factor Va that accelerates protein C activation by thrombin.

J. Miletich, P. Majerus, G. Broze, 1983, The Journal of biological chemistry.

Protein S negates the activated protein C inhibitory activity of plasma

S. Jane, L. Hau, H. Salem, 1992, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Cloning and molecular characterization of a human intracellular serine proteinase inhibitor.

P. Bird, Jiuru Sun, P. Coughlin, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Proteinase inhibitor 6 (PI-6) expression in human skin: induction of PI-6 and a PI-6/proteinase complex during keratinocyte differentiation.

P. Bird, P. Coughlin, J. Paddle-Ledinek, 1998, Experimental cell research.

Regulation of activated protein C by factor Xa

S. Jane, L. Hau, H. Salem, 1991, Blood Coagulation and Fibrinolysis.

Hypercoagulation in glomerulonephritis

J. Whitworth, H. Salem, 1982 .

Production and characterization of recombinant human proteinase inhibitor 6 expressed in Pichia pastoris.

P. Bird, Jiuru Sun, P. Coughlin, 1995, Biochimica et biophysica acta.

Identification and purification of a novel serine proteinase inhibitor.

T. Tetaz, P. Coughlin, H. Salem, 1993, The Journal of biological chemistry.

Effects of thrombomodulin and coagulation Factor Va-light chain on protein C activation in vitro.

C. Esmon, P. Majerus, N. Esmon, 1984, The Journal of clinical investigation.

Hypercoagulation in glomerulonephritis.

J. Whitworth, P. Kincaid‐smith, J. Koutts, 1981, British medical journal.

Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis

E. Wood, P. Coughlin, A. Gallus, 2004, The Medical journal of Australia.

Human thrombomodulin is not an efficient inhibitor of the procoagulant activity of thrombin.

P. Majerus, I. Maruyama, H. Ishii, 1985, The Journal of clinical investigation.

Heparin induced thrombocytopenia. variable dependent platelet aggregating factor

M. Weyden, H. Salem, 1983 .